{"id":"https://openalex.org/W4381617899","doi":"https://doi.org/10.3390/pharmaceutics15071785","title":"Quetiapine Albumin Nanoparticles as an Efficacious Platform for Brain Deposition and Potentially Improved Antipsychotic Activity","display_name":"Quetiapine Albumin Nanoparticles as an Efficacious Platform for Brain Deposition and Potentially Improved Antipsychotic Activity","publication_year":2023,"publication_date":"2023-06-21","ids":{"openalex":"https://openalex.org/W4381617899","doi":"https://doi.org/10.3390/pharmaceutics15071785","pmid":"https://pubmed.ncbi.nlm.nih.gov/37513972","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10385742"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics15071785","doi":"https://doi.org/10.3390/pharmaceutics15071785","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics15071785","pdf_url":"https://www.mdpi.com/1999-4923/15/7/1785/pdf?version=1687341214","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/15/7/1785/pdf?version=1687341214","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052251727","display_name":"Hend Mohamed Abdel\u2010Bar","orcid":"https://orcid.org/0000-0001-5833-9267","observed_orcids":["https://orcid.org/0000-0001-5833-9267"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I338016083","display_name":"University of Sadat City","ror":"https://ror.org/05p2q6194","country_code":"EG","type":"education","lineage":["https://openalex.org/I338016083"]}],"countries":["EG","GB"],"is_corresponding":true,"raw_author_name":"Hend Abdel-Bar","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt","Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King\u2019s College London, London SE1 9NH, UK"],"raw_orcid":"https://orcid.org/0000-0001-5833-9267","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt","institution_ids":["https://openalex.org/I338016083"]},{"raw_affiliation_string":"Institute of Pharmaceutical Science, Faculty of Life Sciences & Medicine, King\u2019s College London, London SE1 9NH, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021669717","display_name":"Alaa S. Tulbah","orcid":"https://orcid.org/0000-0001-9991-7801","observed_orcids":["https://orcid.org/0000-0001-9991-7801"]},"institutions":[{"id":"https://openalex.org/I199693650","display_name":"Umm al-Qura University","ror":"https://ror.org/01xjqrm90","country_code":"SA","type":"education","lineage":["https://openalex.org/I199693650"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Alaa Tulbah","raw_affiliation_strings":["Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-9991-7801","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia","institution_ids":["https://openalex.org/I199693650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069114214","display_name":"Hany W. Darwish","orcid":"https://orcid.org/0000-0002-3437-2748","observed_orcids":["https://orcid.org/0000-0002-3437-2748"]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":true,"raw_author_name":"Hany Darwish","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034740615","display_name":"Rania Salama","orcid":"https://orcid.org/0000-0001-6334-9224","observed_orcids":["https://orcid.org/0000-0001-6334-9224"]},"institutions":[{"id":"https://openalex.org/I2800858616","display_name":"Woolcock Institute of Medical Research","ror":"https://ror.org/04hy0x592","country_code":"AU","type":"facility","lineage":["https://openalex.org/I2799732068","https://openalex.org/I2800858616","https://openalex.org/I99043593"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Rania Salama","raw_affiliation_strings":["Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia","Woolcock Institute of Medical Research, Glebe, NSW 2037, Australia"],"raw_orcid":"https://orcid.org/0000-0001-6334-9224","affiliations":[{"raw_affiliation_string":"Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Woolcock Institute of Medical Research, Glebe, NSW 2037, Australia","institution_ids":["https://openalex.org/I2800858616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087838298","display_name":"Ibrahim Ahmed Naguib","orcid":"https://orcid.org/0000-0002-5923-1466","observed_orcids":["https://orcid.org/0000-0002-5923-1466"]},"institutions":[{"id":"https://openalex.org/I179331831","display_name":"Taif University","ror":"https://ror.org/014g1a453","country_code":"SA","type":"education","lineage":["https://openalex.org/I179331831"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Ibrahim Naguib","raw_affiliation_strings":["Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0002-5923-1466","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, Taif 21944, Saudi Arabia","institution_ids":["https://openalex.org/I179331831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020920447","display_name":"Heba Yassin","orcid":"https://orcid.org/0000-0002-5928-9908","observed_orcids":["https://orcid.org/0000-0002-5928-9908"]},"institutions":[{"id":"https://openalex.org/I4210151980","display_name":"Badr University in Cairo","ror":"https://ror.org/04tbvjc27","country_code":"EG","type":"education","lineage":["https://openalex.org/I4210151980"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Heba Yassin","raw_affiliation_strings":["Department of Pharmaceutics, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt","institution_ids":["https://openalex.org/I4210151980"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025024992","display_name":"Hadel A. Abo El-Enin","orcid":"https://orcid.org/0000-0003-2030-4231","observed_orcids":["https://orcid.org/0000-0003-2030-4231"]},"institutions":[{"id":"https://openalex.org/I4210136593","display_name":"National Organization for Drug Control and Research","ror":"https://ror.org/0407ex783","country_code":"EG","type":"facility","lineage":["https://openalex.org/I4210136593","https://openalex.org/I4210160667","https://openalex.org/I4405259620"]},{"id":"https://openalex.org/I4405259620","display_name":"Egyptian Drug Authority","ror":"https://ror.org/02ff43k45","country_code":"EG","type":"government","lineage":["https://openalex.org/I4210160667","https://openalex.org/I4405259620"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Hadel Abo El-Enin","raw_affiliation_strings":["Department of Pharmaceutics, National Organization of Drug Control and Research (NODCAR) (Previously), Egyptian Drug Authority (Currently), Giza 12511, Egypt"],"raw_orcid":"https://orcid.org/0000-0003-2030-4231","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, National Organization of Drug Control and Research (NODCAR) (Previously), Egyptian Drug Authority (Currently), Giza 12511, Egypt","institution_ids":["https://openalex.org/I4210136593","https://openalex.org/I4405259620"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5052251727","https://openalex.org/A5069114214"],"corresponding_institution_ids":["https://openalex.org/I183935753","https://openalex.org/I28022161","https://openalex.org/I338016083"],"apc_list":{"value":2600,"currency":"CHF","value_usd":2892},"apc_paid":{"value":2600,"currency":"CHF","value_usd":2892},"fwci":0.9165,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.63843293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"15","issue":"7","first_page":"1785","last_page":"1785"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9771000146865845,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11908","display_name":"Protein Interaction Studies and Fluorescence Analysis","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/albumin-nanoparticles","display_name":"albumin nanoparticles","score":0.9470000267028809},{"id":"https://openalex.org/keywords/human-serum-albumin","display_name":"human serum albumin","score":0.9369999766349792},{"id":"https://openalex.org/keywords/brain-targeting","display_name":"brain targeting","score":0.8790000081062317},{"id":"https://openalex.org/keywords/antipsychotic-activity","display_name":"antipsychotic activity","score":0.9240000247955322},{"id":"https://openalex.org/keywords/intravenous-drug-delivery","display_name":"intravenous drug delivery","score":0.7480000257492065},{"id":"https://openalex.org/keywords/desolvation-method","display_name":"desolvation method","score":0.8259999752044678},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8410000205039978},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9909999966621399},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9369999766349792},{"id":"https://openalex.org/keywords/drug-bioavailability","display_name":"drug bioavailability","score":0.550000011920929},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.703227698802948},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6634947657585144},{"id":"https://openalex.org/C2776125364","wikidata":"https://www.wikidata.org/wiki/Q169219","display_name":"Albumin","level":2,"score":0.6396371126174927},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6369974613189697},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6332350969314575},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5921014547348022},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5823052525520325},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.579746425151825},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.47720202803611755},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4194068908691406},{"id":"https://openalex.org/C165616093","wikidata":"https://www.wikidata.org/wiki/Q424232","display_name":"Serum albumin","level":2,"score":0.41700321435928345},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.37748464941978455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22038555145263672},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.17290529608726501},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15803825855255127},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/pharmaceutics15071785","doi":"https://doi.org/10.3390/pharmaceutics15071785","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics15071785","pdf_url":"https://www.mdpi.com/1999-4923/15/7/1785/pdf?version=1687341214","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10385742","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10385742","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10385742/pdf/pharmaceutics-15-01785.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Text"},{"id":"pmid:37513972","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37513972","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:09b021b53c6649cf9ada3304a2562588","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/09b021b53c6649cf9ada3304a2562588","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 15, Iss 7, p 1785 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics15071785","doi":"https://doi.org/10.3390/pharmaceutics15071785","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics15071785","pdf_url":"https://www.mdpi.com/1999-4923/15/7/1785/pdf?version=1687341214","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5009011776","display_name":null,"funder_award_id":"RSPD2023R812","funder_id":"https://openalex.org/F4320321145","funder_display_name":"King Saud University"}],"funders":[{"id":"https://openalex.org/F4320321145","display_name":"King Saud University","ror":"https://ror.org/02f81g417"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4381617899.pdf","grobid_xml":"https://content.openalex.org/works/W4381617899.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W1561356536","https://openalex.org/W1953705156","https://openalex.org/W1983845908","https://openalex.org/W1998571141","https://openalex.org/W2004822031","https://openalex.org/W2009694738","https://openalex.org/W2009974403","https://openalex.org/W2014036031","https://openalex.org/W2015309055","https://openalex.org/W2017367885","https://openalex.org/W2033468374","https://openalex.org/W2036609537","https://openalex.org/W2038982408","https://openalex.org/W2040969349","https://openalex.org/W2051419872","https://openalex.org/W2054164797","https://openalex.org/W2062495745","https://openalex.org/W2077625283","https://openalex.org/W2083533532","https://openalex.org/W2086596085","https://openalex.org/W2087614780","https://openalex.org/W2094760556","https://openalex.org/W2095567970","https://openalex.org/W2104752356","https://openalex.org/W2127294029","https://openalex.org/W2133893914","https://openalex.org/W2144059336","https://openalex.org/W2159202718","https://openalex.org/W2173065268","https://openalex.org/W2233565519","https://openalex.org/W2263785669","https://openalex.org/W2331551237","https://openalex.org/W2346140805","https://openalex.org/W2413518085","https://openalex.org/W2492412658","https://openalex.org/W2590816952","https://openalex.org/W2745847860","https://openalex.org/W2787446985","https://openalex.org/W2791841262","https://openalex.org/W2808374883","https://openalex.org/W2808815533","https://openalex.org/W2895308908","https://openalex.org/W2908569028","https://openalex.org/W3001944340","https://openalex.org/W3009292303","https://openalex.org/W3135732116","https://openalex.org/W3137645885","https://openalex.org/W3164549156","https://openalex.org/W3187641517","https://openalex.org/W3193590905","https://openalex.org/W3196861882","https://openalex.org/W3208672983","https://openalex.org/W4212829300","https://openalex.org/W4283794329","https://openalex.org/W4285096899","https://openalex.org/W4315631399"],"related_works":["https://openalex.org/W4400298522","https://openalex.org/W4394617950","https://openalex.org/W7223278154","https://openalex.org/W3048796127","https://openalex.org/W3164549156","https://openalex.org/W7134942783","https://openalex.org/W3093880023","https://openalex.org/W2508576968","https://openalex.org/W2955377425","https://openalex.org/W2189064065"],"abstract_inverted_index":{"Quetiapine":[0],"(QP)":[1],"is":[2],"a":[3,110,119,140],"second-generation":[4],"short-acting":[5],"antipsychotic":[6,38,84,159,188],"drug":[7,70],"extensively":[8],"metabolized":[9],"in":[10,57,68,77,143],"the":[11,49,83,87,128,148,157,168],"liver,":[12],"producing":[13],"pharmacologically":[14],"inactive":[15],"metabolites":[16],"and":[17,40,67,75,99,118,166,186],"leading":[18],"to":[19,26,104,147],"diminished":[20],"bioavailability.":[21],"Therefore,":[22],"this":[23],"study":[24],"aimed":[25],"develop":[27],"an":[28],"intravenous":[29,129,178],"QP":[30,37,106,120,132,136,150,153,158,183],"albumin":[31,44,95,107,133,154],"nanoparticles":[32],"(NPs)":[33],"system":[34],"for":[35],"improving":[36],"activity":[39,85],"brain":[41,137,184],"targeting.":[42],"QP-loaded":[43],"NPs":[45,54,108,134,155,180],"were":[46,55,79,102],"prepared":[47],"by":[48,162],"desolvation":[50],"method.":[51],"The":[52,152,173],"fabricated":[53],"characterized":[56],"terms":[58],"of":[59,86,113,122,131],"particle":[60,111],"size,":[61],"zeta":[62],"potential,":[63],"entrapment":[64],"efficiency":[65,145],"(EE%),":[66],"vitro":[69],"release.":[71],"In":[72,81,126],"vivo":[73],"pharmacokinetics":[74],"biodistribution":[76],"rats":[78],"studied.":[80],"addition,":[82,127],"optimized":[88],"platform":[89],"was":[90],"also":[91],"investigated.":[92],"Human":[93],"serum":[94],"(HSA)":[96],"concentration,":[97],"pH,":[98],"stirring":[100],"time":[101],"modulated":[103],"optimize":[105],"with":[109,139],"size":[112],"103.54":[114],"\u00b1":[115,124],"2.36":[116],"nm":[117],"EE%":[121],"96.32":[123],"3.98%.":[125],"administration":[130],"facilitated":[135],"targeting":[138,144,185],"4.9-fold":[141],"increase":[142],"compared":[146],"oral":[149],"solution.":[151],"improved":[156],"activity,":[160],"indicated":[161],"suppressing":[163],"rats'":[164],"hypermobility":[165],"reducing":[167],"QP's":[169],"extrapyramidal":[170],"side":[171],"effects.":[172],"obtained":[174],"results":[175],"proposed":[176],"that":[177],"QP-":[179],"could":[181],"improve":[182],"its":[187],"efficiency.":[189]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-23T00:00:00"}